The polycystic ovary disorder (PCOS) is characterized as a mix of hyperandrogenism (hirsutism and skin break out) and anovulation (oligomenorrhea, barrenness, and useless uterine seeping), with or without the nearness of polycystic ovaries on ultrasound. It speaks to the primary endocrine issue in the conceptive age, influencing 6% - 15% of ladies in threats. It is the most widely recognized reason for barrenness because of anovulation, and the primary wellspring of female fruitlessness. At the point when in the pre-since of a menstrual issue, the finding of PCOS is come to in 30% - 40% of patients with essential or auxiliary amenorrhea and in 80% of patients with oligomenorrhea. PCOS ought to be analyzed and treated right off the bat in pre-adulthood because of conceptive, metabolic and ontological difficulties which might be related with it. Treatment choices incorporate medications, diet and way of life improvement. For solid youthful couples, the probability of getting pregnancy differs. In 2010, an expected 48.5 million couples worldwide were barren. This paper gives a survey on barrenness causes, examinations, treatment modalities and job of medical attendant birthing specialist in managing fruitless couples. Barrenness (a condition of sub richness) can be showed either as the failure to wind up pregnant, powerlessness to maintain a pregnancy, and failure to proceed with a pregnancy till term. There are different reasons for female and male fruitlessness.
Cite this article:
Kanchan R. Pagar, Kajal J. Bodake, Mansi G. Shinde, Nikita P. Ghumare. Effect of Ultraviolet Radiation on various Bacterial Species. Asian Journal of Pharmaceutical Research. 2023; 13(1):71-4. doi: 10.52711/2231-5691.2023.00014
Kanchan R. Pagar, Kajal J. Bodake, Mansi G. Shinde, Nikita P. Ghumare. Effect of Ultraviolet Radiation on various Bacterial Species. Asian Journal of Pharmaceutical Research. 2023; 13(1):71-4. doi: 10.52711/2231-5691.2023.00014 Available on: https://www.asianjpr.com/AbstractView.aspx?PID=2023-13-1-14
1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic Ovary Syndrome. Nature Reviews Disease Primers. 2016; 2:16057.
2. Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed Diagnosis and a Lack of Information Associated with Dissatisfaction in Women with Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2017; 102:604-12.
3. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound Assessment of the Polycystic Ovary: International Consensus Definitions. Hum Reprod Update. 2003; 9:505-14.
4. Escobar-Morreale HF. Polycystic Ovary Syndrome: Definition, Aetiology, Diagnosis and Treatment. Nature Reviews Endocrinology. 2018; 14:270-84.
5. Cooney LG, Dokras A. Beyond Fertility: Polycystic Ovary Syndrome and Long-Term Health. Fertil Steril. 2018; 110(5):794-809.
6. El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol. 2016; 7:124. doi: 10.3389/fphys.2016.00124.
7. Achard C, Thiers J. Le virilisme pilaire et son association a` l’insuffisance glycolytique (diabe`te des femme a` barbe). Bull Acad Natl Med. 1921; 86:5183.
8. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998; 83:3078-82.
9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, et al. A survey of the polycystic ovarysyndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84:4006-11.
10. ovary syndrome in women in China: A large community-based study. Hum Reprod 2013; 28:2562-9
11. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts health across the lifespan. BMC Medicine 2010; 8:4
12. Nicole Gala, RN, is a PCOS and author of “The Everything Fertility Book”.
13. Lujan ME, Chizen DR, Pierson RA. Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies. J Obstet Gynaecol Can. 2008; 30:671-79
14. Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic Ovarian Syndrome (PCOS): Long-Term Metabolic Consequences. Metabolism Clinical and Experimental. 2018; 86:33-43.
15. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006; 12(6): 673–683.
16. Martins Wde P, Soares GM, Vieira CS, dos Reis RM, de Sá MF, Ferriani RA. Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance. Rev Bras Ginecol Obstet. 2009; 31(3):111–116
17. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7:219–2311
18. Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and metaanalysis. Hum Reprod Update. 2014; 20(5):748–758
19. Gainder S, Sharma B. Update on Management of Polycystic Ovarian Syndrome for Dermatologists. Indian Dermatol Online J. 2019; 10:97-105.
20. Polycystic Ovary Syndrome. ACOG Practice Bulletin No. 194. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018; 131:e157-71.
21. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al.; Endocrine Society. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2013; 98:4565-92.